The Bulletin
The Times


.

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

  • Written by PR Newswire
  • Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing over US$100B per year
  • Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases, but has limited disease-modifying therapeutics
  • Promising efficacy results in cardiovascular performance observed in Cohort A...
hacklink hack forum hacklink film izle hacklink Galabetjojobetjojobetjojobetcasinos not on gamstopnon uk casinosnot on gamstopcasinos not on gamstopcasinos non gamblock ukiptviptvzlibraryzlibraryz-libraryIQOSdeneme bonusuPadişahbetvippark kayıtPadişahbetdeneme bonusulunabet girişPadişahbettaraftarium24Sahabet girişjojobetjojobetjojobetviljo kasinot kirjautuminenGalabetzimpler kasinotGalabet1xbetjojobet girişcasibomcasibombetparkmatbetmatbetjojobet